CSTONE PHARMA-B

02616

Current ValuationThe current P/E ratio is -18.13, within the reasonable range, cheaper than 68.4% of the time in the past 5 years, and the industry ranks 59/78, the industry Median -5.01.

-18.13xP/E
Stock priceHK$5.48Earnings per shareHK$-0.30

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0158316474632

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-74.88x75.50%HK$83.39B
09688HKZAI LAB
-16.45x17.69%HK$25.60B
01877HKJUNSHI BIO
-35.02x83.59%HK$16.09B
07666HKMETIS TECHBIO-P
-32.37x96.67%HK$13.18B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
06855HKASCENTAGE
-6.46x19.08%HK$10.93B
09606HKDUALITYBIO-B
-5.96x85.35%HK$9.87B
01952HKEVEREST MED
-153.55x326.79%HK$9.53B
02595HKGENFLEET-B
-5.95x66.07%HK$9.02B
02616HKCSTONE PHARMA-B
-18.13x1.09%HK$8.75B
02493HKMABWELL-B
-6.63x--HK$8.11B
09887HKLEADS BIOLABS-B
-25.08x3.57%HK$7.71B
06938HKRIBOLIFE-B
-39.45x29.56%HK$7.71B
02335HKMICOT PHARMA-B
-16.86x37.52%HK$7.07B
02171HKCARSGEN-B
-64.59x52.33%HK$6.63B
09966HKALPHAMAB-B
-29.30x--HK$5.94B
00775HKCKLIFE SCIENCES
-80.22x--HK$5.19B
01672HKASCLETIS-B
-7.38x78.53%HK$5.02B
02256HKABBISKO-B
-8.87x797.83%HK$4.77B
01779HKLONGBIO-B
-19.01x--HK$4.73B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.